BIOSPAIN 2026: Full Schedule

14:30 CEST

Boosting biotechnology development accelerators

Tuesday September 29, 2026 14:30 - 15:15 CEST

The Biotech Act will establish the first comprehensive framework to promote biotechnology as a strategic sector for the European Union’s competitiveness, public health, sustainability, and technological autonomy. The law aims to position Europe in the global competition with the United States and China in this strategically important field.
About fostering biotechnology startup companies in the health sector, the Biotech Act outlines the structural conditions and mechanisms needed to accelerate innovation and improve the translation of research into market applications, so that such initiatives may be recognized by the Commission as “high impact health biotechnology strategic projects”.
The Biotech Act advocates for achieving critical mass through clusters - not hundreds of small biotechnology hubs scattered everywhere - but rather half a dozen large “super-clusters” capable of attracting substantial investment and offering strong, competitive capacities in innovation, manufacturing, and infrastructure.

-Lilly, pendiente ponente

Moderators

Amelia Martín Uranga

Director of Clinical and Translational Research, FARMAINDUSTRIA

Amelia Martín Uranga, PhD in Law, Director of Clinical and Translational Research and Head of the Innovative Medicines Platform (Farmaindustria), focuses primarily on the implementation and management of public-private partnership projects, such as the BEST Project and the Pharma-Biotech... Read More →

Speakers

María José Lallena Jimeno

Directora del Centro de Investigación, Desarrollo e Innovación, Fundación LILLY

Doctora en Bioquímica y Biología Molecular por la Universidad Autónoma de Madrid. Su trayectoria profesional se inició con dos periodos postdoctorales: el primero de ellos en el Centro de Biología Molecular de Madrid y el segundo, en el Laboratorio Europeo de Biología Molecular... Read More →

Idoia Muñoz Lizán

Managing Director, Basque Health Cluster

Núria Martí

Director of Innovation and Business Development, Biocat

Núria Martí Ras has an undergraduate degree in Veterinary Sciences (Autonomous University of Barcelona, 1993), PhD in Veterinary Sciences (UAB, 1999), master’s in Laboratory Animal Science and Welfare (UAB, 2009) and a master’s in R&D Management in Health from the Carlos III... Read More →

Javier Jiménez

Chief Medical Officer, Pharmamar

Experienced healthcare professional with over two decades of experience leading evidence generation strategies and research at some of the world’s most prestigious pharmaceutical and health technology companies. As Chief Medical Officer at PharmaMar, I drive the integration clinical... Read More →

Marisol Quintero

COO, Highlight Therapeutics

Tuesday September 29, 2026 14:30 - 15:15 CEST
2 Dorotea Barnés room

Round table discussion

SPONSOR FARMAINDUSTRIA
Audience English language
Track Health

BIOSPAIN 2026